Overview
Miguel Seabra practices in Lisbon, Portugal. Mr. Seabra and is rated as an Experienced expert by MediFind in the treatment of CLN1 Disease. His top areas of expertise are Choroideremia, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Glutaric Acidemia Type 2.
His clinical research consists of co-authoring 90 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of CLN1 Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- ChoroideremiaMr. Seabra isElite. Learn about Choroideremia.
- Advanced
- Late-Onset Retinal DegenerationMr. Seabra isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Experienced
- Age-Related Macular Degeneration (ARMD)Mr. Seabra isExperienced. Learn about Age-Related Macular Degeneration (ARMD).
- Batten DiseaseMr. Seabra isExperienced. Learn about Batten Disease.
- CLN1 DiseaseMr. Seabra isExperienced. Learn about CLN1 Disease.
- CLN2 DiseaseMr. Seabra isExperienced. Learn about CLN2 Disease.
- CLN3 DiseaseMr. Seabra isExperienced. Learn about CLN3 Disease.
- CLN4 DiseaseMr. Seabra isExperienced. Learn about CLN4 Disease.